Complex interactions in a novel SCN5A compound mutation associated with long QT and Brugada syndrome: Implications for Na+ channel blocking pharmacotherapy for de novo conduction disease.

about

Complex interactions in a novel SCN5A compound mutation associated with long QT and Brugada syndrome: Implications for Na+ channel blocking pharmacotherapy for de novo conduction disease.

Item

http://www.wikidata.org/entity/Q55538633

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Complex interactions in a nove ...... or de novo conduction disease.

@en

Complex interactions in a nove ...... or de novo conduction disease.

@nl

type

Item

label

Complex interactions in a nove ...... or de novo conduction disease.

@en

Complex interactions in a nove ...... or de novo conduction disease.

@nl

prefLabel

Complex interactions in a nove ...... or de novo conduction disease.

@en

Complex interactions in a nove ...... or de novo conduction disease.

@nl

P1476

Complex interactions in a nove ...... or de novo conduction disease.

@en

P2093

Danna Spears

http://www.w3.org/2001/XMLSchema#string

Edward J Vigmond

http://www.w3.org/2001/XMLSchema#string

Jason D Bayer

http://www.w3.org/2001/XMLSchema#string

Jie Liu

http://www.w3.org/2001/XMLSchema#string

Marianne Wauchop

http://www.w3.org/2001/XMLSchema#string

Michael Gollob

http://www.w3.org/2001/XMLSchema#string

Peter H Backx

http://www.w3.org/2001/XMLSchema#string

Robert Tsushima

http://www.w3.org/2001/XMLSchema#string

Roozbeh Aschar-Sobbi

http://www.w3.org/2001/XMLSchema#string

P2860

Interaction of batrachotoxin with the local anesthetic receptor site in transmembrane segment IVS6 of the voltage-gated sodium channel

Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation

Long QT syndrome with compound mutations is associated with a more severe phenotype: a Japanese multicenter study.

A common SCN5A polymorphism modulates the biophysical defects of SCN5A mutations

Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy.

Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome.

An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing.

Voltage-dependent and Ca2(+)-activated ion channels in human neutrophils

Unique mixed phenotype and unexpected functional effect revealed by novel compound heterozygosity mutations involving SCN5A.

Long QT syndrome and life threatening arrhythmia in a newborn: molecular diagnosis and treatment response

P304

e0197273

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0197273

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Vijay S Chauhan

P577

2018-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29791480

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy

P932

5965851

http://www.w3.org/2001/XMLSchema#string